Courier Capital LLC Has $1.20 Million Stake in Stryker Co. (NYSE:SYK)

Courier Capital LLC lifted its position in shares of Stryker Co. (NYSE:SYK) by 19.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,357 shares of the medical technology company’s stock after purchasing an additional 543 shares during the quarter. Courier Capital LLC’s holdings in Stryker were worth $1,201,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Burkett Financial Services LLC acquired a new position in shares of Stryker during the fourth quarter worth approximately $25,000. Farmers & Merchants Trust Co of Chambersburg PA raised its position in shares of Stryker by 203.3% during the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 61 shares during the period. Rogco LP acquired a new position in shares of Stryker during the fourth quarter worth approximately $30,000. DSM Capital Partners LLC acquired a new position in shares of Stryker during the fourth quarter worth approximately $34,000. Finally, HBC Financial Services PLLC acquired a new position in shares of Stryker during the fourth quarter worth approximately $37,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Robert W. Baird upped their target price on Stryker from $367.00 to $378.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 1st. Evercore ISI upped their price target on Stryker from $340.00 to $370.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. UBS Group upped their price target on Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a report on Wednesday, May 1st. Needham & Company LLC upgraded Stryker from a “hold” rating to a “buy” rating and set a $392.00 price target for the company in a report on Wednesday, May 22nd. Finally, StockNews.com upgraded Stryker from a “hold” rating to a “buy” rating in a report on Tuesday. Four analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $370.58.

Stryker Stock Down 0.0 %

SYK stock opened at $340.43 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The company has a market capitalization of $129.69 billion, a price-to-earnings ratio of 38.86, a PEG ratio of 2.68 and a beta of 0.92. Stryker Co. has a fifty-two week low of $249.98 and a fifty-two week high of $361.41. The stock has a fifty day moving average of $337.38 and a 200-day moving average of $333.39.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.36 by $0.14. The company had revenue of $5.24 billion during the quarter, compared to the consensus estimate of $5.10 billion. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.14 EPS. As a group, equities research analysts predict that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 dividend on an annualized basis and a yield of 0.94%. Stryker’s dividend payout ratio (DPR) is 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.